Table 1

Anthropometric and baseline laboratory measurements and 2-h post-OGTT plasma glucose levels of the four groups consisting of women with NGT and GDM during pregnancy and after delivery

NGT during pregnancyGDM during pregnancyNGT after deliveryFormer GDM after delivery
N715715
Body height (cm)168 ± 2162 ± 2168 ± 2162 ± 2
Body weight (cm)81.0 ± 6.183.9 ± 4.476.5 ± 6.4#79.7 ± 4.7#
BMI (kg/m2)28.4 ± 1.432.0 ± 1.726.8 ± 1.5#30.3 ± 1.7#
Age (years)34 ± 233 ± 134 ± 2#34 ± 1#
Serum creatinine (mg/dL)0.64 ± 0.030.58 ± 0.030.80 ± 0.07#0.75 ± 0.04 #
Serum triglycerides (mg/dL)252 (101)161 (65)79 (111)#85 (92)#
Serum cholesterol (mg/dL)261 ± 17235 ± 14193 ± 9#218 ± 18
Serum HDL cholesterol (mg/dL)83 ± 1169 ± 461 ± 460 ± 5#
HbA1c (%)5.1 ± 0.15.2 ± 0.15.5 ± 0.2#5.5 ± 0.1#
FFAs (µmol/L)424 ± 52566 ± 36*434 ± 72612 ± 44*
Gestational week27.1 ± 0.725.5 ± 0.4*
OGTT
Fasting glucose (mg/dL)83 ± 291 ± 393 ± 3#94 ± 3
1-h Post-OGTT plasma glucose (mg/dL)159 ± 7194 ± 4*161 ± 19171 ± 8#
2-h Post-OGTT plasma glucose (mg/dL)127 ± 6152 ± 6*126 ± 14122 ± 9#
  • Data are given as means ± SE except for triglycerides: median (interquartile range); paired Student t test for intraindividual analyses, unpaired Student t test for NGT vs. GDM during pregnancy and after delivery.

  • *P < 0.04 GDM vs. NGT.

  • #P < 0.02 after vs. during pregnancy.